Annex 2Participants at the Guideline Development Group meeting

Publication Details

Guideline Development Group members

  • Dr AMANULLAH, Farhana
    Consultant Paediatrician
    Director Paediatric TB Program
    The Indus Hospital, Korangi Crossing, Karachi
    PAKISTAN
  • Dr CHAKHAIA, Tsira (via webinar)
    ACSM Advisor, Civil Society Georgia
    USAID Georgia TB Prevention Project
    University Research Co., LLC
    57 Shartava Street
    0178 – Tbilisi
    GEORGIA
  • Dr CIRILLO, Daniela Maria
    Head
    Emerging Bacterial Pathogens Unit
    Fondazione Centro San Raffaele
    Via Olgettina, 60
    20132 – Milano
    ITALY
  • Dr DOOLEY, Kelly (Co-chair)
    Associate Professor of Medicine
    Pharmacology & Molecular Science
    Divisions of Clinical Pharmacology & Infectious Diseases
    Johns Hopkins University School of Medicine, Center for Tuberculosis Research
    600 N. Wolfe Street, Osler 527
    21287 - Baltimore, MD
    UNITED STATES
  • Dr DO VALLE BASTOS, Luis Gustavo
    Capacity Building Team Leader
    Stop TB Partnership’s Global Drug
    Facility (GDF)
    Chemin de Blandonnet 2
    1214 – Geneva
    SWITZERLAND
  • Dr DU CROS, Philipp
    Research Advisor
    Médecins Sans Frontières
    67-74 Saffron Hill
    EC1N 8QX – London
    UNITED KINGDOM
  • Prof DUARTE, Raquel
    TB consultant
    National HIV/AIDS/TB Programme
    Hospital Centre of Vila Nova de
    Gaia/Espinho,
    Medical School, Porto University
    Institute of Public Health, Porto University
    Porto
    PORTUGAL
  • Professor KUABAN, Christopher
    Dean, Faculty of Health Sciences
    University of Bamenda, Cameroon
    Bamenda, North West Region
    CAMEROON
  • Dr LANIADO-LABORIN, Rafael
    Head, TB Clinic, Hospital
    General de Tijuana
    Instituto Estatal de Salud de Baja California
    Tijuana
    MEXICO
  • Professor MAARTENS, Gary
    Faculty of Health Sciences
    Division of Clinical Pharmacology
    Department of Medicine
    University of Cape Town
    7925 - Observatory
    SOUTH AFRICA
  • Professor MARYANDYSHEV, Andrei
    Head of Phthisiopulmonary Department
    Northern State Medical University
    Troitsky 51, 163061 - Arkhangelsk
    RUSSIAN FEDERATION
  • Dr MONEDERO-RECUERO, Ignacio
    MDR-TB and TB-HIV Consultant
    International Union of TB and Lung
    Disease (The Union)
    68, boulevard Saint-Michel
    F-75006 Paris
    FRANCE
  • Dr QUELAPIO, Maria Imelda Josefa
    Senior Consultant
    KNCV TB Foundation
    P.O. Box 146
    Van Bylandt Huis
    Benoordenhoutsweg 46
    2596 BC – The Hague
    NETHERLANDS
  • Dr REECHAIPITKUL, Wipa
    Professor
    Department of Medicine
    Faculty of Medicine
    Khon Kaen University
    123 Mittraparb Rd., A. Muang
    40002 - Khon Kaen
    THAILAND
  • Dr RICH, Michael
    Global Health Physician
    Partners in Health
    Harvard Medical School
    641 Huntington Avenue
    02115 - Boston, MA
    UNITED STATES
  • Dr SANTESSO, Nancy (Co-chair)
    Assistant Professor
    Department of Health Research Methods,
    Evidence, and Impact
    Deputy Director, Cochrane Canada
    Health Sciences Centre, Rm 2C, McMaster
    University
    1280 Main Street West
    Hamilton ON L8S 4L8
    CANADA
  • Dr SAVIC, Rada
    Associate Professor
    Department of Bioengineering and Therapeutic Sciences
    Division of Pulmonary and Critical
    Care Medicine
    Schools of Pharmacy and Medicine
    University of California San Francisco
    1700 4th Street, Box 2552
    San Francisco, CA 94158
    UNITED STATES
  • Dr SIKHONDZE, Welile
    National Tuberculosis Control Programme
    Advisor and Research Coordinator
    Mbabane
    SWAZILAND
  • Dr VAN DEUN, Armand
    Bacteriology Consultant
    Department of Biomedical Sciences
    Mycobacteriology Unit
    Prince Leopold Institute of Tropical
    Medicine
    Nationalestraat 155
    B-2000 – Antwerpen
    BELGIUM

Observers

  • Professor MIGLIORI, Giovanni Battista
    Director, WHO Collaborating Centre for TB and Lung Diseases
    Fondazione S. Maugeri, Care and Research Institute
    21049 - Tradate
    ITALY
  • Dr MUKADI, Ya Diul
    Medical Officer
    Tuberculosis Division/Infectious
    Disease Office
    Global Health Bureau
    USAID – CP3 #10094A
    1300 Pennsylvania Avenue NW
    Washington, DC 20523
    UNITED STATES
  • Dr NAHID, Payam
    Professor of Medicine
    Division of Pulmonary and Critical Care Medicine
    University of California
    San Francisco General Hospital
    1001 Potrero Ave, 5K1
    94110 – San Francisco CA
    UNITED STATES
  • Dr RODWELL, Timothy
    Foundation for Innovative New Diagnostics (FIND)
    Avenue de Budé 16
    1202 - Geneva
    SWITZERLAND
  • Dr YASSIN, Mohammed
    Senior Advisor
    The Global Fund
    Chemin de Blandonnet 8
    1214 Vernier – Geneva
    SWITZERLAND

Evidence Reviewers

  • Dr MENZIES, Dick
    Director, Respiratory Division
    MUHC and McGill University,
    Room K1.24
    Montréal Chest Institute
    3650 St. Urbain
    H2X 2P4 – Montréal, PQ
    CANADA
  • Dr FREGONESE, Federica
    McGill University Health Centre
    Montréal, Quebec,
    CANADA

WHO/HQ Secretariat

  • Dr WEYER, Karin, Coordinator, HQ/HTM/GTB/LDR
  • Dr FALZON, Dennis, Medical Officer, HQ/HTM/GTB/LDR
  • Mr GAO Xu, Intern, HQ/HTM/GTB/RTE
  • Mr van GEMERT, Wayne, Technical Officer, HQ/HTM/GTB/LDR
  • Dr GILPIN, Christopher, Scientist, HQ/HTM/GTB/LDR
  • Ms GONZÁLEZ-ANGULO, Licé, Technical Officer, HQ/HTM/GTB/RTE
  • Dr JARAMILLO, Ernesto, Medical Officer, HQ/HTM/GTB/LDR
  • Dr KOROBITSYN, Alexei, Technical Officer, HQ/HTM/GTB/LDR
  • Dr MIRYAZEV, Fuad, Medical Officer, HQ/HTM/GTB/LDR
  • Dr OLLIARO, Piero, Unit Leader, Intervention Research, HQ/HTM/TDR/IIR
  • Dr ZIGNOL, Matteo, Scientist, HQ/HTM/GTB/TME